V
Vijay Yajnik
Researcher at Harvard University
Publications - 111
Citations - 6272
Vijay Yajnik is an academic researcher from Harvard University. The author has contributed to research in topics: Inflammatory bowel disease & Crohn's disease. The author has an hindex of 33, co-authored 105 publications receiving 5334 citations. Previous affiliations of Vijay Yajnik include Cleveland Clinic & Columbia University Medical Center.
Papers
More filters
Journal ArticleDOI
Imaging in Patients with Crohn's Disease: Trends in Abdominal CT/MRI Utilization and Radiation Exposure Considerations over a 10-Year Period.
Hamed Kordbacheh,Vinit Baliyan,Jessica Serrao,Michael S. Gee,Vijay Yajnik,Dushyant V. Sahani,Avinash Kambadakone +6 more
TL;DR: A 9-fold growth in annual MR scan volume contributed to a nearly 2-fold rise in yearly cross-sectional imaging utilization in Crohn's patients between 2006 and 2015, which paralleled a 60% reduction of CT radiation exposure.
Journal ArticleDOI
Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel Diseases.
Jordan E. Axelrad,Ahmad Najdat Bazarbashi,James Zhou,Daniel Castaneda,Amandeep Gujral,Dylan Sperling,Jason Glass,Manasi Agrawal,Simon Hong,Garrett Lawlor,David Hudesman,Shannon Chang,Shailja C. Shah,Vijay Yajnik,Ashwin N. Ananthakrishnan,Hamed Khalili,Jean-Frederic Colombel,Steven H. Itzkowitz,New York Crohn’s +18 more
TL;DR: It is found that patients with IBD and breast or prostate cancer who receive hormone therapy have an increased risk for relapse of inflammatory bowel diseases and related adverse outcomes.
Journal ArticleDOI
Effect of oral tobacco use and smoking on outcomes of Crohn's disease in India.
Umang Arora,Ashwin N. Ananthakrishnan,Saurabh Kedia,Sawan Bopanna,Pratap Mouli,Dawesh P Yadav,Govind K. Makharia,Vijay Yajnik,Vineet Ahuja +8 more
TL;DR: The study aimed to assess the association between smoking or OT and outcomes in CD and found no link between smoking and outcomes.
Journal ArticleDOI
Integrin αM activation and upregulation on esophageal eosinophils and periostin-mediated eosinophil survival in eosinophilic esophagitis.
Praveen Vimalathas,Alexandra Farris,Dorothea Letner,Vikram Deshpande,Vijay Yajnik,Wayne G. Shreffler,John J. Garber +6 more
TL;DR: It is found that resting eosinophils express high levels of the β2‐pairing integrins αL and αM, and lower levels of α4, α6 and α4β7, and the migration of peripheral eos inophils to the esophagus is characterized by the specific induction of αM.
Journal ArticleDOI
Challenges in IBD Research: Novel Technologies.
Manish Dhyani,Nitin Joshi,Willem A. Bemelman,Michael S. Gee,Vijay Yajnik,André D'Hoore,Giovanni Traverso,Mark Donowitz,Gustavo Mostoslavsky,Timothy K. Lu,Neil Lineberry,Heiko G. Niessen,Dan Peer,Jonathan Braun,Conor P. Delaney,Marla Dubinsky,Ashley N. Guillory,Maria J. N. Pereira,Nataly Shtraizent,Gerard Honig,David Brent Polk,Andrés Hurtado-Lorenzo,Jeffrey M. Karp,Fabrizio Michelassi +23 more
TL;DR: The novel technologies section is focused on prioritizing unmet clinical needs in IBD that will benefit from novel technologies applied to: non-invasive detection and monitoring of active inflammation and assessment of treatment response; mucosal targeted drug delivery systems; and prevention of post-operative septic complications and treatment of fistulizing complications.